Dmytro Havrylyuk
Ph.D. Danylo Halytsky Lviv National Medical University (DH LNMU), Lviv, Ukraine, 2007
Medicinal chemistry, organic and inorganic synthesis
Pharmacy
Selected publications prior to UK:
1. Havrylyuk D., Zimenkovsky B., Lesyk R. Synthesis, biological activity of thiazolidinones bearing indoline moiety and isatin based hybrids. Mini-Reviews in Organic Chemistry, 2015, 12, 66-87.
2. Havrylyuk D., Zimenkovsky B., Karpenko O., Grellier P., Lesyk R. Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity. European Journal of Medicinal Chemistry, 2014, 85, 245-254.
3. Avdieiev S., Gera L., Hodges R.S., Havrylyuk D., Lesyk R., Ribrag V., Vassetzky Y., Kavsan V. Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds. Bioorganic & Medicinal Chemistry. 2014, 22, 3815–3823. 4
4. Havrylyuk D., Zimenkovsky B., Vasylenko O., Lesyk R. Synthesis, anticancer and antiviral activity of new 2- pyrazoline substituted 4-thiazolidinones. J. Heterocyclic Chem. 2013, 50, E55-E62.
5. Havrylyuk D., Zimenkovsky B., Vasylenko O., Day C.W., Smee D.F., Grellier P., Lesyk R. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. European Journal of Medicinal Chemistry. 2013, 66, 228-237.
6. Havrylyuk D., Zimenkovsky B., Vasylenko O., Gzella A., Lesyk R. Synthesis of new 4-thiazolidinone, pyrazoline, and isatin-based conjugates with promising antitumor activity. J. Med. Chem. 2012, 55, 8630−8641.
7. Havrylyuk D., Kovach N.,Zimenkovsky B., Vasylenko O.,Lesyk R. Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates. Arch. Pharm. Chem. LifeSci. 2011, 344, 514–522.
8. Havrylyuk D., Mosula L., Zimenkovsky B., Vasylenko O., Gzella A., Lesyk R. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. European Journal of Medicinal Chemistry. 2010, 45, 5012-5021.
9. Havrylyuk D., Zimenkovsky B., Vasylenko O., Zaprutko L., Gzella A., Lesyk R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. European Journal of Medicinal Chemistry, 2009, 44(4), 1396-1404.
- "Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions." Photochemistry and photobiology 96, 2 (2020): 327-339. Details. Full text
- "Ru(ii) complexes with diazine ligands: electronic modulation of the coordinating group is key to the design of "dual action" photoactivated agents." Chemical communications (Cambridge, England) 54, 88 (2018): 12487-12490. Details. Full text
- "Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines." European journal of medicinal chemistry 156, (2018): 790-799. Details. Full text
- "Photochemical Properties and Structure-Activity Relationships of Ru<sup>II</sup> Complexes with Pyridylbenzazole Ligands as Promising Anticancer Agents." European journal of inorganic chemistry 2017, 12 (2017): 1687-1694. Details.
- "Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids." European journal of medicinal chemistry 113, (2016): 145-66. Details. Full text
